In an era where precision medicine is becoming the standard, the physical infrastructure of healthcare—specifically the delivery of Durable Medical Equipment (DME) and orthotics—has remained stubbornly analog. Patients often face weeks of waiting for vital devices, stalled by fragmented communication between clinicians, insurers, and manufacturers. Hike Medical, a San Francisco-based health-tech innovator, is moving to bridge this gap.
The company recently announced a successful $22.5 million Series A funding round, a significant capital injection aimed at digitizing and automating the notoriously opaque supply chain for medical devices. With this investment, Hike intends to transition from its initial focus on custom insoles to a comprehensive, AI-driven platform designed to serve the broader DME landscape.
The Core Mission: Bridging the "Communication Gap"
At the heart of Hike Medical’s strategy is a simple, yet ambitious, premise: medical systems should not be silos. Currently, the process of ordering a custom orthotic or a piece of DME involves multiple disconnected stakeholders: the physician, the insurance provider, the billing department, and the manufacturer. This "swivel-chair" workflow often leads to administrative errors, rejected claims, and, most critically, prolonged patient suffering.
"Patients shouldn’t have to wait weeks for a device because the systems behind their care don’t talk to each other," says Aadi Bhanti, CEO of Hike Medical. "We have a duty to make it better. We’ve proven this model in custom foot orthotics, making the process faster, more accurate, and built around the patient instead of the paperwork."
By leveraging AI and integrated software, Hike is positioning its platform as the "operating system" for medical device procurement, aiming to slash the turnaround time for custom equipment to under five business days.
Chronology: From Niche Solution to Industry Disruptor
Hike Medical’s journey began in 2022 with a specific focus on the diabetic population. The company recognized that for diabetic patients, custom orthotic insoles are not merely a matter of comfort—they are a critical component of wound prevention and mobility.
- 2022: Hike Medical is founded in San Francisco, launching with an initial focus on streamlining the procurement of custom diabetic insoles.
- 2023: The company establishes its high-tech 3D printing laboratory in Peoria, Illinois. This move allows Hike to bring manufacturing in-house, creating a vertical integration model that bypasses traditional third-party delays.
- 2024: Hike begins rolling out its integrated "Hike Clinical" tool, allowing clinicians to perform scanning, documentation, and ordering within a single digital workflow.
- 2025 (Mid-Year): The platform begins to see widespread adoption among podiatry and O&P (Orthotics and Prosthetics) providers.
- August 2026: The company announces a $22.5 million Series A funding round led by Saga Ventures, marking a strategic pivot toward expanding its service to the entire DME market.
Supporting Data: The Anatomy of the Platform
Hike’s solution is built on a tripartite infrastructure designed to harmonize the point of care with the point of manufacture.
1. Hike Intelligence (The Brain)
This layer utilizes sophisticated AI agents to handle the "heavy lifting" of administrative tasks. These agents process referrals, verify insurance coverage, and automate the authorization process. By reducing the reliance on manual data entry, the system minimizes human error, which is the leading cause of claim denials in the medical device sector.
2. Hike Clinical (The Interface)
This tool is the clinician’s primary dashboard. It integrates directly into existing clinical workflows, allowing doctors to scan patients for orthotics, document clinical necessity, and place orders without leaving the point-of-care setting. By centralizing these tasks, Hike eliminates the "fax-and-file" culture that still permeates many medical offices.
3. The Peoria Manufacturing Hub (The Engine)
Hike’s 3D printing laboratory represents the physical manifestation of its speed-to-market goal. By owning the production facility, Hike controls the entire pipeline. According to the company’s internal data, they are currently capable of delivering custom-manufactured equipment within approximately five business days—a drastic improvement over the industry standard, which can often exceed three to four weeks.
Official Responses and Strategic Backing
The $22.5 million investment was not just a vote of confidence from a single entity but a broad coalition of financial backers who see the potential for disruption in the healthcare supply chain.
The round was led by Saga Ventures, with significant participation from:
- Indicator Ventures
- Fifth Down Capital
- RiverPark Ventures
Notably, the round also attracted high-profile individual investors, including former New England Patriots coach Jerod Mayo. The involvement of diverse venture capital firms suggests a consensus that the "medical device supply chain" is a ripe target for digital transformation, akin to the fintech or e-commerce revolutions of the past decade.
In his official statement, CEO Aadi Bhanti emphasized that the capital will be deployed aggressively. "We’re taking it across the rest of device-based care," Bhanti stated. The funds are earmarked for two primary areas: expanding the engineering and sales teams at the San Francisco headquarters and scaling the manufacturing capacity at the Peoria site to accommodate a wider variety of DME products.
Implications for the Future of Healthcare
The timing of Hike Medical’s expansion comes at a critical juncture for global supply chains. Over the past year, the healthcare sector has faced mounting pressure from geopolitical instability and environmental volatility. Disruptions in global trade routes, such as the instability near the Straits of Hormuz, and an increase in extreme weather events have highlighted the fragility of traditional, globally-dispersed manufacturing models.
Reshoring and Domestic Resilience
By investing in domestic manufacturing in Peoria, Illinois, Hike is leaning into the "reshoring" trend. By keeping the manufacturing process within the United States, the company is insulating its supply chain from international logistics disruptions. This is a massive competitive advantage for healthcare providers who cannot afford to have their patients wait on a container ship for essential orthotic equipment.
The Shift to "Patient-Centric" Procurement
The broader implication of Hike’s model is the transition toward a "patient-first" procurement cycle. In the current system, the patient is often a passive bystander, waiting for a device while the provider struggles with the paperwork. Hike’s technology effectively turns the patient into the center of a streamlined workflow. As the company expands into the broader DME market—which includes mobility aids, respiratory equipment, and more—the potential to reduce health complications resulting from delayed equipment access is substantial.
Challenges Ahead
While the technology is promising, Hike faces the significant challenge of hospital system integration. Most large health systems utilize massive Electronic Health Record (EHR) platforms like Epic or Cerner. For Hike to truly achieve its vision of "managing the entire supply chain," it must prove that its platform can interoperate seamlessly with these incumbent giants.
Furthermore, as they move into the broader DME space, Hike will need to navigate a more complex regulatory and reimbursement landscape than they encountered with custom foot orthotics. Each class of DME carries its own set of billing codes, clinical documentation requirements, and quality standards.
Conclusion
Hike Medical represents a new wave of health-tech companies that are looking beyond the "software-only" model. By marrying high-level AI intelligence with tangible, high-speed 3D manufacturing, they are addressing the root causes of supply chain inefficiency. As they deploy their $22.5 million in funding, the industry will be watching closely to see if they can maintain their five-day turnaround promise as they scale to serve thousands of additional clinics and patients nationwide.
In an industry where every day of delay can mean the difference between a patient’s mobility or recovery, Hike Medical’s push for speed and integration is not just a business strategy—it is a necessary evolution of patient care.
About the Author
